Shares of Transcat, Inc. (NASDAQ:TRNS) have been assigned an average broker rating score of 1.33 (Strong Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating and two have assigned a strong buy rating to the company. Transcat’s rating score has improved by 11.3% in the last 90 days as a result of various analysts’ upgrades and downgrades.
Analysts have set a one year consensus target price of $20.00 for the company and are predicting that the company will post $0.23 EPS for the current quarter, according to Zacks. Zacks has also assigned Transcat an industry rank of 46 out of 265 based on the ratings given to its competitors.
A number of research firms recently commented on TRNS. Singular Research upped their price target on shares of Transcat from $15.30 to $20.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Zacks Investment Research upgraded shares of Transcat from a “hold” rating to a “buy” rating and set a $18.00 target price for the company in a report on Wednesday, February 14th. Roth Capital assumed coverage on shares of Transcat in a report on Friday, February 9th. They set a “buy” rating and a $20.00 target price for the company. Finally, ValuEngine upgraded shares of Transcat from a “hold” rating to a “buy” rating in a report on Wednesday, April 11th.
In other Transcat news, Director John T. Smith sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $15.70, for a total transaction of $31,400.00. Following the completion of the transaction, the director now owns 33,100 shares of the company’s stock, valued at $519,670. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 8.80% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Northern Trust Corp increased its position in shares of Transcat by 9.5% during the second quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock valued at $220,000 after acquiring an additional 1,570 shares in the last quarter. Wedge Capital Management L L P NC purchased a new stake in Transcat in the fourth quarter worth approximately $378,000. Deutsche Bank AG boosted its holdings in Transcat by 86.8% in the fourth quarter. Deutsche Bank AG now owns 33,695 shares of the scientific and technical instruments company’s stock worth $480,000 after purchasing an additional 15,653 shares during the last quarter. QCI Asset Management Inc. NY boosted its holdings in Transcat by 62.8% in the fourth quarter. QCI Asset Management Inc. NY now owns 52,467 shares of the scientific and technical instruments company’s stock worth $748,000 after purchasing an additional 20,233 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in Transcat by 118.8% in the fourth quarter. Renaissance Technologies LLC now owns 53,394 shares of the scientific and technical instruments company’s stock worth $761,000 after purchasing an additional 28,994 shares during the last quarter. 55.22% of the stock is owned by institutional investors.
TRNS stock traded down $0.10 during midday trading on Thursday, reaching $16.65. 1,260 shares of the company’s stock traded hands, compared to its average volume of 11,499. The stock has a market capitalization of $119.45, a price-to-earnings ratio of 26.02, a PEG ratio of 2.31 and a beta of 0.42. Transcat has a 52 week low of $11.60 and a 52 week high of $17.20. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.38.
Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.09. The firm had revenue of $40.48 million for the quarter. Transcat had a net margin of 3.24% and a return on equity of 10.03%. equities research analysts anticipate that Transcat will post 0.7 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This article was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/04/19/brokerages-anticipate-transcat-inc-trns-to-announce-0-23-eps.html.
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services.
Get a free copy of the Zacks research report on Transcat (TRNS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.